Key provisions
- No proof of intent (RCW 21.20.010). A seller can be liable for a material misrepresentation or omission without any showing of intent to defraud; negligence can suffice. The defense is reasonable care, not innocence of motive.
- Rescission, interest, and fees (RCW 21.20.430(1)). A defrauded buyer may unwind the purchase and recover the consideration paid, plus 8% interest, costs, and reasonable attorneys' fees — or damages if the security is gone.
- Control persons and material aiders carry the burden (RCW 21.20.430(3)). Those who control a seller, or materially aid a sale — directors, officers, controlling investors — are jointly and severally liable unless they prove they neither knew nor, in the exercise of reasonable care, could have known of the violation.
- Anti-waiver. Waivers of the Act are void, and the Washington Supreme Court has held equitable defenses such as waiver and estoppel unavailable to a seller. Contractual releases and sophistication disclaimers may not foreclose a statutory claim.
- A discovery-based deadline (RCW 21.20.430(4)(b)). Fraud claims run three years from when the violation was discovered or, with reasonable care, should have been discovered. Registration-only claims run three years from the sale, with no discovery rule.
Insights for investors
- Your leverage is the burden of proof. You need not prove the seller meant to deceive you — only that a statement was materially false or a material fact was omitted.
- Rescission plus fees changes the math. Recovering your money with interest and shifting your attorneys' fees makes otherwise-uneconomic claims worth pursuing.
- Your best facts are usually the silence. Investors prevail most often on what was concealed, not on optimistic projections, which sellers defend as opinion.
- Watch the clock. The three-year discovery period is generous only until a court decides you were on inquiry notice; document when and how you learned the truth.
Insights for VCs and fund managers
- You sit on both sides. As a buyer you hold the investor rights above; as an insider, a board seat or controlling stake can make the fund and its principals jointly liable for a portfolio company's misstatements, with the burden on you to prove reasonable care.
- Diligence is a liability defense, not just value protection. The reasonable-care defense is only as good as your documentation of what you reviewed and relied on.
- Your own fund documents are a sale of securities. Offering interests through a PPM or LPA makes you a seller subject to the same antifraud rules; because waivers are void, disclaimers may not save you.
- Mind the long tail on exits and earn-outs. Representations about historical facts can surface as claims years later under the discovery rule.
Insights for investment advisers
- Advice itself can trigger liability. The Act reaches advisers who engage in fraudulent or dishonest conduct; a recommendation built on a company's false disclosures can expose you as a material aider.
- Document suitability and conflicts. Your defense is a contemporaneous record: why the recommendation fit the client, what you disclosed, and what diligence you did on the issuer.
- Regulators act independently. The Division of Securities can pursue enforcement regardless of whether a private claim is filed.
What the case data shows
Hundreds of decisions have issued under RCW 21.20 in the decades since the law was first passed in 1959. Based on our analysis, a few notable patterns emerged. Composition by industry, of 250+ decisions:
- General / unclear: 73 (29%)
- Financial services / brokerage / banking: 68 (27%)
- Technology / internet / telecom: 32 (13%)
- Franchise / consumer / other business: 29 (12%)
- Real estate / construction: 27 (11%)
- Professional services (law / accounting): 12 (5%)
- Energy / natural resources: 10 (4%)
One trend that materializes consistently across six decades is that Washington courts have viewed cases based on omissions and nondisclosure favorably. Three decisions illustrate the doctrine:
- Go2Net v. Freeyellow.com, 158 Wn.2d 247 (2006). A buyer of an internet company recovered after the seller failed to disclose a third party's ownership claim; the Supreme Court held the seller could not escape through waiver or estoppel.
- Hines v. Data Line Systems, 114 Wn.2d 127 (1990). Investors needed only to show the misrepresentation was material and relied upon — no loss-causation hurdle — and outside directors were exposed as control persons for the company's omissions.
- Guarino v. Interactive Objects, 122 Wn. App. 95 (2004). Insiders who repurchased a departing shareholder's stock without disclosing a pending, value-changing transaction were held liable for both fraud and negligent misrepresentation.
Where claims fail: the defense view
The features that help investors also mark the openings for the defense. Most RCW 21.20 claims that fail do so on threshold or fact-specific grounds rather than on a finding that nothing was misrepresented.
- The statute of limitations is the most common defense, but it is fact-bound. It carries only where the plaintiff's inquiry notice is undisputed; a genuine dispute about when the fraud was or should have been discovered defeats it.
- Seller and "substantial contributive factor" status is the decisive line for secondary actors. Accountants, lawyers, and other advisers avoid liability where their role was routine professional service rather than active participation in the sale.
- The reasonable-care and good-faith defenses turn on documentation. Control persons and material aiders bear the burden, but a contemporaneous diligence record can carry it.
- Opinion, puffery, and forward-looking statements are not actionable facts, and reliance fails where the investor held contradictory information and did not investigate.
- Dispositive motions tend to succeed on legal-threshold grounds — whether the instrument was a security, whether the defendant was a seller, release, res judicata, or an available exemption — while materiality, reliance, and the discovery date are usually questions for the jury.
Compliance takeaways
Because liability attaches to what was said and left unsaid, the controls that reduce it are disclosure discipline and a diligence record.
- Build the disclosure schedule around known adverse facts — litigation, competing ownership or IP claims, related-party arrangements, and key-person risks — because omissions, not projections, drive liability.
- Document diligence as it happens. The reasonable-care defense is only as strong as the record of what was reviewed and relied on.
- Treat every offering document as a sale of securities. Because waivers of the Act are void, disclaimers and integration clauses will not substitute for accurate disclosure.
- Preserve the communications that show what investors were told and when, since the discovery-based deadline turns on that record.